AI filing briefs · archive

8-K filings in May 2024, explained

278 material Form 8-K filings that 243 companies we cover made with the SEC in May 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).

Clear

26 of 278 briefs match

newest first · times in ET
CVCOCAVCO INDUSTRIES, INC. May 23, 7:07 PM ET

Cavco Industries fiscal Q4 profit falls 28% on 12% lower revenue

Negative earnings Written later 2.02

Cavco Industries reported fiscal fourth-quarter net revenue of $420 million, down 11.8%, and net income attributable to common stockholders of $34 million, down 28.3%. For the fiscal year ended March 30, 2024, net revenue was $1.8 billion, down 16.2%, and diluted earnings per share were $18.37 compared with $26.95, as lower home sales volume and lower selling prices reduced results for shareholders.

  • Fourth-quarter diluted EPS was $4.03 versus $5.39 a year earlier; factory-built housing gross margin was 22.4% versus 24.4%.
  • Full-year net revenue was $1,795 million versus $2,143 million, and income before income taxes was $199 million, down 35.2%.
  • Backlog was $191 million at March 30, 2024, down from $244 million at April 1, 2023.
  • Stock repurchases were approximately $110 million in the fiscal year; management will hold a conference call on May 24, 2024 at 1:00 p.m. Eastern.
Read the filing on SEC.gov ↗
KEYSKeysight Technologies, Inc. May 20, 4:06 PM ET

Keysight Q2 revenue falls 13% to $1.22 billion; EPS drops, full-year outlook unchanged

Negative earnings Written later 2.02

Keysight reported second-quarter fiscal 2024 revenue of $1.22 billion, down from $1.39 billion a year earlier, and GAAP diluted EPS of $0.72 versus $1.58. The company said results were above the high end of its guidance and left its full-year outlook unchanged, while its third-quarter guidance calls for revenue of $1.18 billion to $1.20 billion and non-GAAP EPS of $1.30 to $1.36.

  • Q2 revenue was $1.22 billion, down 13% from $1.39 billion in Q2 2023.
  • GAAP net income was $126 million, or $0.72 per diluted share, versus $283 million, or $1.58, a year earlier.
  • Non-GAAP EPS was $1.41, compared with $2.12 in Q2 2023.
  • Q3 fiscal 2024 guidance: revenue of $1.18 billion to $1.20 billion and non-GAAP EPS of $1.30 to $1.36.
Read the filing on SEC.gov ↗
DXCDXC Technology Co May 16, 4:21 PM ET

DXC Q4 revenue down 5.7% to $3.39 billion; Q4 GAAP loss of $195 million

Negative earnings Written later 2.02

DXC reported fourth-quarter fiscal 2024 revenue of $3.39 billion, down 5.7% from a year earlier, and a net loss of $195 million, narrower than the $758 million loss a year earlier. Non-GAAP diluted EPS fell to $0.97 from $1.02, and fiscal 2025 guidance projects revenue of $12.67 billion to $12.95 billion, below fiscal 2024's $13.67 billion, which may weigh on shareholders.

  • Q4 FY24 revenue was $3.39 billion, down 5.7%, and down 4.9% on an organic basis
  • Q4 FY24 diluted EPS was $(1.10) versus $(3.38); non-GAAP diluted EPS was $0.97 versus $1.02
  • FY25 guidance: revenue of $12.67 billion to $12.95 billion and non-GAAP diluted EPS of $2.50 to $3.00, versus $3.13 in FY24
Read the filing on SEC.gov ↗
DXPEDXP ENTERPRISES INC May 9, 1:08 PM ET

DXP Enterprises Q1 EPS falls to $0.67 as sales drop 2.7% from a year earlier

Negative earnings Written later 2.02

DXP Enterprises reported first-quarter 2024 results on May 8, 2024. Sales were $412.6 million, down 2.7% from $424.3 million a year earlier, and GAAP diluted EPS was $0.67, down from $0.95, while net income fell to $11.3 million from $17.6 million. Acquisitions contributed $11.8 million of sales, and the company generated $24.1 million of free cash flow, but the year-over-year declines in sales and profit are the headline measures for shareholders.

  • Sales of $412.6 million, up 1.4% sequentially from $407.0 million but down 2.7% from $424.3 million in Q1 2023
  • GAAP diluted EPS of $0.67 versus $0.95 a year earlier; non-GAAP diluted EPS of $0.74
  • Adjusted EBITDA of $40.3 million versus $43.1 million; free cash flow of $24.1 million, up 6.4%
  • Cash of $139.7 million and net debt of $407.6 million at March 31, 2024; CFO expects growth to be driven by the second half of 2024
Read the filing on SEC.gov ↗

Medical Properties Trust posts $736 million Q1 net loss on $693 million impairments

Negative earnings Written later 2.02

Medical Properties Trust reported a first-quarter net loss of $736 million ($1.23 per share), compared with net income of $33 million a year earlier, driven by $693 million in impairments tied mainly to Steward Health Care. Normalized FFO fell to $142 million ($0.24 per share) from $222 million ($0.37), and the company approved $75 million in debtor-in-possession financing after Steward filed for Chapter 11, which matters to shareholders given the sharp drop in earnings and the impairment charges.

  • Net loss of $736 million ($1.23 per share) vs. net income of $33 million ($0.05 per share) a year earlier; impairments of $693 million included a full reserve on an approximately $360 million Steward loan.
  • Normalized FFO of $142 million ($0.24 per share) vs. $222 million ($0.37) a year earlier, primarily due to a significant decrease in Steward-related revenue.
  • MPT approved $75 million in debtor-in-possession financing for Steward after its Chapter 11 filing; the financing is subject to bankruptcy court approval.
  • Executed $1.6 billion in year-to-date liquidity transactions, 80% of the initial 2024 target, and now expects to exceed the $2.0 billion target.
Read the filing on SEC.gov ↗
SBHSally Beauty Holdings, Inc. May 9, 6:45 AM ET

Sally Beauty Q2 sales fall 1.1% to $908 million; GAAP EPS $0.27 vs. $0.37 a year ago

Negative earnings Written later 2.027.01

Sally Beauty Holdings reported fiscal second-quarter 2024 net sales of $908.4 million, down 1.1% from the prior year, with GAAP diluted earnings per share of $0.27 versus $0.37. The company updated its fiscal 2024 outlook, now expecting an adjusted operating margin of about 8.5%, and said it expects net sales and comparable sales to be roughly flat.

  • Q2 net sales were $908.4 million, down 1.1%; comparable sales fell 1.5%.
  • GAAP diluted EPS was $0.27 versus $0.37 a year earlier; adjusted diluted EPS was $0.35 versus $0.41.
  • Fiscal 2024 guidance: gross margin of 50.5% to 51.0%, adjusted operating margin about 8.5%, operating cash flow about $240 million.
  • The company issued a $600 million note due 2032 at a 6.75% coupon to refinance its $680 million note due 2025.
Read the filing on SEC.gov ↗
MMIMarcus & Millichap, Inc. May 7, 8:21 PM ET

Marcus & Millichap Q1 net loss widens to $10.0 million as revenue falls 16.6%

Negative earnings Written later 2.025.07

Marcus & Millichap reported first-quarter 2024 total revenue of $129.1 million, down 16.6% from $154.8 million a year earlier, and a net loss of $10.0 million, or $0.26 per diluted share, compared with a net loss of $5.8 million, or $0.15 per share. The company attributed the decline to fewer transactions in a challenging market, and it has not yet filed its Form 10-Q, so the results are preliminary.

  • Brokerage commissions fell 18.9% to $109.5 million, primarily on a 13.8% decrease in the number of transactions.
  • Net loss was $10.0 million, or $0.26 per diluted share, versus $5.8 million, or $0.15 per diluted share, in the first quarter of 2023.
  • Adjusted EBITDA was $(10.1) million, compared with $(7.4) million a year earlier.
  • At the May 2, 2024 annual meeting, the say-on-pay proposal passed with 25,888,652 votes for and 10,534,106 against.
Read the filing on SEC.gov ↗
BIOBIO-RAD LABORATORIES, INC. May 7, 4:18 PM ET

Bio-Rad Q1 sales fall 9.8% to $610.8 million; full-year 2024 outlook maintained

Negative earnings Written later 2.02

Bio-Rad reported first-quarter 2024 net sales of $610.8 million, down 9.8% from a year earlier, with Life Science sales down 25.3% and Clinical Diagnostics up 4.7%. GAAP net income rose to $383.9 million, or $13.45 per diluted share, mainly due to a $422.2 million gain on equity securities tied to its Sartorius AG holding, while non-GAAP net income fell to $65.2 million, or $2.29 per share, from $3.34 a year earlier.

  • Net sales $610.8 million vs. $676.8 million in Q1 2023, a 9.8% decline; Life Science down 25.3%, Clinical Diagnostics up 4.7%
  • Income from operations $44.7 million vs. $61.9 million; non-GAAP operating margin 9.7% vs. 12.4%
  • GAAP net income $383.9 million ($13.45 per diluted share) vs. $69.0 million ($2.32), driven by changes in the fair market value of Sartorius AG-related equity securities
  • Full-year 2024 outlook maintained: non-GAAP currency-neutral revenue growth of approximately 1.0% to 2.5% and non-GAAP operating margin of approximately 13.5% to 14.0%
Read the filing on SEC.gov ↗
DEIDouglas Emmett Inc May 7, 4:10 PM ET

Douglas Emmett Q1 revenue falls 2.9% to $245.0 million; 2024 guidance unchanged

Negative earnings Written later 2.02

Douglas Emmett reported first quarter 2024 results, with revenue down 2.9% to $245.0 million and net income attributable to common stockholders down 51.5% to $8.9 million, or $0.05 per diluted share. The company left its full-year 2024 FFO per share guidance of $1.64 to $1.70 unchanged, citing expected higher interest expense, so shareholders face lower first quarter earnings with no change to the outlook.

  • Revenue fell 2.9% to $245.0 million, as lower office occupancy and the removal of Barrington Plaza apartments offset higher residential and parking revenue.
  • FFO fell 8.7% to $90.1 million, or $0.45 per fully diluted share, mainly due to higher interest expense and lower revenues.
  • 2024 guidance: net income per diluted share of $0.04 to $0.10 and FFO per fully diluted share of $1.64 to $1.70, both unchanged.
  • Quarterly dividend of $0.19 per common share was paid on April 16, 2024.
Read the filing on SEC.gov ↗
ICUIICU MEDICAL INC/DE May 7, 4:07 PM ET

ICU Medical Q1 2024 net loss widens to $39.5 million; adjusted EPS falls to $0.96

Negative earnings Written later 2.02

ICU Medical reported first quarter 2024 revenue of $566.7 million, down slightly from $568.6 million a year earlier, and a GAAP net loss of $39.5 million, or $1.63 per diluted share, versus a $9.8 million loss, or $0.41 per share, in the first quarter of 2023. Adjusted diluted earnings per share fell to $0.96 from $1.74, and adjusted EBITDA fell to $78.8 million from $102.0 million, so headline profit measures declined for shareholders.

  • Q1 2024 revenue was $566.7 million versus $568.6 million in Q1 2023.
  • GAAP net loss was $39.5 million, or $1.63 per diluted share, versus a $9.8 million loss, or $0.41 per share, a year earlier.
  • Adjusted diluted EPS was $0.96 versus $1.74; adjusted EBITDA was $78.8 million versus $102.0 million.
  • The filing includes a fiscal year 2024 outlook showing a GAAP net loss of $127 million to $110 million and adjusted diluted EPS of $4.40 to $5.10.
Read the filing on SEC.gov ↗
NPOEnpro Inc. May 7, 7:21 AM ET

Enpro Q1 2024 sales fall 8.9% to $257.5 million; profit and EPS drop sharply

Negative earnings Written later 2.02

Enpro reported first quarter 2024 results on May 7, 2024. Sales fell 8.9% to $257.5 million, GAAP income from continuing operations fell to $12.5 million from $26.0 million, and adjusted diluted EPS fell 19.5% to $1.57, driven mainly by weakness in the Advanced Surface Technologies segment. The company kept its full-year 2024 guidance unchanged, which shareholders may weigh against the weaker quarter.

  • Sales of $257.5 million, down 8.9%; organic sales down 11.6%
  • GAAP diluted EPS from continuing operations of $0.59 versus $1.24 a year earlier
  • Adjusted EBITDA of $58.4 million, down 14.9%; Advanced Surface Technologies sales down 21.4%
  • Full-year 2024 guidance maintained: adjusted EBITDA of $260-$280 million and adjusted diluted EPS of $7.00 to $7.80
Read the filing on SEC.gov ↗
VNOVORNADO REALTY TRUST May 6, 4:37 PM ET

Vornado swings to Q1 2024 net loss of $9.0 million; FFO as adjusted falls to $0.55 a share

Negative earnings Written later 2.02

Vornado Realty Trust reported a first-quarter 2024 net loss attributable to common shareholders of $9.0 million, or $0.05 per diluted share, compared with net income of $5.2 million, or $0.03 per share, a year earlier. Revenues fell to $436.4 million from $445.9 million, and FFO as adjusted dropped to $108.8 million, or $0.55 per diluted share, from $116.3 million, or $0.60.

  • Net loss attributable to common shareholders was $9,034,000 ($0.05 per diluted share) versus net income of $5,168,000 ($0.03) in Q1 2023.
  • FFO attributable to common shareholders plus assumed conversions, as adjusted, was $108,847,000 ($0.55 per diluted share) versus $116,288,000 ($0.60).
  • Same store NOI at share decreased 4.8% year over year, with New York down 4.6% and THE MART down 10.0%.
  • Revenues were $436,375,000 versus $445,923,000 a year earlier.
Read the filing on SEC.gov ↗

Sunstone Q1 2024 net income falls 38% to $13.0 million; quarterly dividend raised 29%

Negative earnings Written later 2.025.07

Sunstone Hotel Investors reported first-quarter 2024 net income of $13.0 million, down 38.2% from a year earlier, as comparable RevPAR fell 5.1% and Adjusted EBITDA re declined 9.2% to $54.5 million. The company said it reaffirmed the midpoint of its prior earnings guidance, as adjusted for its April acquisition of the Hyatt Regency San Antonio Riverwalk for a contractual purchase price of $230.0 million, and raised its quarterly common dividend to $0.09 per share. Stockholders also voted on directors, the auditor and executive pay at the May 3, 2024 annual meeting.

  • Net income was $13.0 million versus $21.1 million; income attributable to common stockholders was $0.05 per diluted share versus $0.08.
  • Comparable RevPAR fell 5.1% to $223.06; Adjusted EBITDA re fell 9.2% to $54.5 million.
  • Quarterly common dividend increased $0.02 to $0.09 per share (29%), payable July 15, 2024 to holders of record as of June 28, 2024.
  • Full-year 2024 Adjusted EBITDA re guidance is $242 million to $263 million with the midpoint unchanged; the net income guidance midpoint rose $4 million to a range of $56 million to $77 million.
Read the filing on SEC.gov ↗
MPMP Materials Corp. / DE May 2, 4:13 PM ET

MP Materials Q1 revenue falls 49% to $48.7 million; diluted EPS is $(0.08) loss

Negative earnings Written later 2.02

MP Materials reported first-quarter 2024 results with revenue down 49% year over year to $48.7 million, as realized rare earth oxide prices fell 54% and sales volumes fell 9%. Net income fell 56% to $16.5 million, helped by a $46.3 million gain on early debt repayment, and Adjusted EBITDA swung to a $(1.2) million loss. For shareholders, the results show weaker profitability, while the company also repurchased 7.3% of its shares and issued $747.5 million of new convertible notes due 2030.

  • Revenue fell to $48.7 million from $95.7 million, driven by a 54% drop in realized price per REO metric ton to $4,294.
  • Diluted EPS was $(0.08) versus $0.20 a year earlier; Adjusted Diluted EPS was $(0.04) versus $0.27.
  • Adjusted EBITDA was $(1.2) million versus $58.7 million, with higher cost of sales and a $6.0 million reserve tied to Stage II start-up.
  • In March 2024 the company repurchased 13.0 million shares, or 7.3% of shares outstanding, at $15.43 per share, and issued $747.5 million of 3.0% convertible notes due 2030.
Read the filing on SEC.gov ↗
COHUCOHU INC May 2, 4:09 PM ET

Cohu posts $14.6 million first-quarter loss on $107.6 million sales

Negative earnings Written later 2.02

Cohu reported fiscal first-quarter 2024 net sales of $107.6 million, down from $179.4 million a year earlier, and a GAAP net loss of $14.6 million, or $0.31 per share, compared with net income of $15.7 million a year earlier. The company guided second-quarter 2024 sales to $105 million, plus or minus $6 million, so shareholders face a weaker revenue base and a GAAP loss in the latest quarter.

  • First-quarter net sales of $107.6 million, versus $179.4 million in Q1 FY 2023 and $137.2 million in Q4 FY 2023
  • GAAP net loss of $14.6 million, or $0.31 per share; non-GAAP net income of $0.6 million, or $0.01 per share
  • Second-quarter 2024 sales expected at $105 million, plus or minus $6 million
  • Repaid remaining Term Loan B on February 9, 2024 with a $29.3 million payment; repurchased 333,504 shares for about $10.7 million
Read the filing on SEC.gov ↗
DMCDEL MONTE CORP May 2, 4:09 PM ET

Fresh Del Monte Q1 net income falls to $26.1 million; sales $1,107.9 million

Negative earnings Written later 2.02

Fresh Del Monte Produce Inc. (NYSE: FDP) reported first-quarter 2024 results for the quarter ended March 29, 2024, with net sales of $1,107.9 million, down from $1,128.5 million a year earlier. Net income attributable to the company fell to $26.1 million, or $0.55 per diluted share, from $39.0 million, or $0.81, which matters to shareholders because lower banana sales and margins outweighed growth in fresh and value-added products.

  • Net sales were $1,107.9 million versus $1,128.5 million; banana net sales fell to $379.5 million from $425.1 million.
  • Fresh and value-added products net sales rose to $676.8 million from $643.4 million, and avocado revenue increased 23% on higher pricing.
  • Banana gross margin fell to 5.7% from 10.2%, and adjusted diluted EPS was $0.34 versus $0.55.
  • The board declared a quarterly cash dividend of $0.25 per share, payable June 7, 2024, to holders of record on May 16, 2024.
Read the filing on SEC.gov ↗

International Bancshares Q1 net income falls 4.2% to $97.3 million

Negative earnings Written later 2.02

International Bancshares Corporation reported net income of $97.3 million, or $1.56 per diluted share, for the three months ended March 31, 2024. That was down 4.2% in net income and 4.3% in diluted EPS from $101.6 million, or $1.63 per diluted share, a year earlier. Management cited a higher provision for credit losses, mainly a charge-down of an impaired credit after a bankruptcy-related foreclosure, as a drag on results.

  • Q1 2024 net income $97.3 million ($1.56 diluted EPS) vs. $101.6 million ($1.63) in Q1 2023
  • Provision for credit losses increased, primarily from a charge-down of an impaired credit after a bankruptcy-related foreclosure
  • Total assets $15.4 billion and deposits $12.0 billion at March 31, 2024, up from $15.1 billion and $11.8 billion at December 31, 2023
Read the filing on SEC.gov ↗
IDAIDACORP INC May 2, 8:15 AM ET

IDACORP Q1 profit falls to $48.2 million, or $0.95 a share; 2024 guidance reaffirmed

Negative earnings Written later 2.027.01

IDACORP reported first-quarter 2024 net income of $48.2 million, or $0.95 per diluted share, down from $56.1 million, or $1.11 per share, a year earlier. The company reaffirmed its full-year 2024 earnings guidance of $5.25 to $5.45 per diluted share, but said capital spending could be higher than previously projected as it works through its resource request for proposal process.

  • Q1 2024 net income attributable to IDACORP was $48.2 million, or $0.95 per diluted share, versus $56.1 million, or $1.11, in Q1 2023.
  • Lower usage per retail customer reduced Idaho Power net income by $9.1 million, and depreciation expense rose $8.6 million, due to more moderate temperatures and higher plant-in-service.
  • Full-year 2024 EPS guidance of $5.25 to $5.45 was reaffirmed, with Idaho Power capital expenditures of $925 million to $975 million unchanged.
  • Management said it may need higher capital spending than previously projected to meet rapid customer and load growth.
Read the filing on SEC.gov ↗
VMCVulcan Materials CO May 2, 7:30 AM ET

Vulcan Materials Q1 revenue falls to $1.55 billion; earnings drop, outlook kept

Negative earnings Written later 2.02

Vulcan Materials reported first-quarter 2024 results on May 2, 2024. Total revenues were $1.55 billion, down from $1.65 billion a year earlier, and net earnings attributable to Vulcan were $103 million, down from $121 million. Management said all aspects of its outlook from February remain unchanged, including $2.15 to $2.30 billion of 2024 Adjusted EBITDA, so shareholders see lower first-quarter earnings alongside unchanged full-year targets.

  • Total revenues were $1,546 million versus $1,649 million; diluted EPS from continuing operations was $0.78 versus $0.92.
  • Adjusted diluted EPS from continuing operations was $0.80 versus $0.95, and Adjusted EBITDA was $323 million versus $338 million.
  • Aggregates shipments fell to 48.1 million tons from 51.8 million, while freight-adjusted sales price rose to $20.59 per ton from $18.69.
  • The company expects 2024 Adjusted EBITDA of $2.15 to $2.30 billion and used $550 million of cash on hand to redeem its 2026 notes.
Read the filing on SEC.gov ↗
ADAMADAMAS TRUST, INC. May 1, 4:23 PM ET

New York Mortgage Trust swings to $68.3 million Q1 loss, or $0.75 per share

Negative earnings Written later 2.027.01

New York Mortgage Trust (Nasdaq: NYMT) reported a first-quarter 2024 net loss attributable to common stockholders of $68.3 million, or $0.75 per share, compared with net income of $10.5 million, or $0.12 per share, a year earlier. Book value per common share fell to $10.21 from $11.31 at December 31, 2023, and management attributed the decline mainly to impairments in its multi-family joint venture equity investments. The filing names New York Mortgage Trust, not Adamas Trust, and uses ticker NYMT rather than ADAM as the request stated.

  • Net loss attributable to common stockholders of $68.3 million ($0.75 per share) for the three months ended March 31, 2024, versus net income of $10.5 million ($0.12 per share) in the same quarter of 2023
  • Total other loss of $57.3 million, including $36.2 million of real estate impairments and $39.4 million of net unrealized losses
  • Book value per common share of $10.21 at March 31, 2024, versus $11.31 at December 31, 2023; adjusted book value per common share of $11.51
  • Dividend of $0.20 per common share; earnings conference call scheduled for Thursday, May 2, 2024 at 9:00 a.m. Eastern Time
Read the filing on SEC.gov ↗
CRKCOMSTOCK RESOURCES INC May 1, 4:21 PM ET

Comstock Resources swings to $14.5 million Q1 net loss as gas prices weaken

Negative earnings Written later 2.02

Comstock Resources reported a first-quarter 2024 net loss of $14.5 million, or $0.05 per share, compared with net income of $134.5 million, or $0.49 per diluted share, a year earlier. Total revenues fell to $335.8 million from $489.6 million, and the company said continued weak natural gas prices weighed heavily on results, which matters to shareholders because earnings and cash flow both declined sharply.

  • Total revenues were $335.8 million, down from $489.6 million in the first quarter of 2023.
  • Net loss was $14.5 million, or $0.05 per share, versus net income of $134.5 million, or $0.49 per diluted share, a year earlier.
  • Adjusted net loss was $8.5 million, or $0.03 per share; adjusted EBITDAX was $230 million versus $293.5 million.
  • Average natural gas price was $2.06 per Mcf, down from $2.98, and operating cash flow was $182.0 million versus $254.9 million.
Read the filing on SEC.gov ↗

Advanced Energy Q1 2024 revenue falls to $327.5 million; GAAP EPS $0.15

Negative earnings Written later 2.02

Advanced Energy reported first-quarter 2024 revenue of $327.5 million, down from $425.0 million a year earlier and $405.3 million in the fourth quarter of 2023, and the company said revenue was below its guidance. GAAP diluted EPS from continuing operations fell to $0.15 from $0.84 a year earlier, and non-GAAP EPS was $0.58 versus $1.24, so profit declined sharply. The company guided second-quarter 2024 revenue to $350 million plus or minus $20 million.

  • Q1 2024 revenue was $327.5 million, compared with $425.0 million in Q1 2023 and $405.3 million in Q4 2023.
  • GAAP diluted EPS from continuing operations was $0.15, versus $0.84 in Q1 2023; non-GAAP diluted EPS was $0.58, versus $1.24.
  • Q1 2024 GAAP net income from continuing operations was $5.8 million, compared with $31.8 million a year earlier.
  • Q2 2024 guidance: revenue of $350 million +/- $20 million; GAAP EPS of $0.25 +/- $0.25; non-GAAP EPS of $0.73 +/- $0.25.
Read the filing on SEC.gov ↗
MOSMOSAIC CO May 1, 4:08 PM ET

Mosaic Q1 net earnings fall to $45 million as lower fertilizer prices cut revenue 26%

Negative earnings Written later 2.02

Mosaic reported first quarter 2024 results on May 1, 2024, with net earnings of $45 million, or $0.14 per diluted share, down from $435 million a year earlier. Revenue fell 26% to $2.7 billion on lower selling prices, and the company cited $165 million in after-tax notable items, mainly a foreign currency transaction loss, an unrealized derivatives loss and an environmental reserve adjustment. The sharp drop in earnings and adjusted EBITDA means shareholders received a weaker quarter, though the company also reported $178 million returned to shareholders so far in 2024.

  • Revenue of $2.7 billion, down 26% from the year-ago period, reflecting lower selling prices; gross margin rate was 14.9% versus 18.6%.
  • Diluted EPS of $0.14 versus $1.28 a year earlier; adjusted EPS of $0.65 versus $1.14.
  • Adjusted EBITDA of $576 million versus $777 million; free cash flow of $203 million versus $191 million.
  • Second quarter guidance: potash sales volumes of 2.2-2.4 million tonnes and phosphate sales volumes of 1.6-1.8 million tonnes.
Read the filing on SEC.gov ↗
CNXNPC CONNECTION INC May 1, 4:05 PM ET

Connection Q1 net sales fall 13.1% to $632.0 million; net income down 7.4%

Negative earnings Written later 2.027.01

Connection reported first-quarter 2024 net sales of $632.0 million, down 13.1% year over year, which management attributed to customers delaying IT capital spending. Net income fell 7.4% to $13.2 million, or $0.50 per diluted share, although gross margin rose 187 basis points to 18.7%. The board also declared a $0.10 quarterly dividend and raised the share repurchase authorization by $40.0 million to $120.0 million, of which $72.1 million is available.

  • Net sales were $632.0 million, down 13.1% from $727.5 million; Public Sector Solutions sales fell 33.4% to $93.5 million
  • Net income was $13.2 million, or $0.50 per diluted share, versus $14.2 million, or $0.54, a year earlier
  • Gross margin expanded 187 basis points to 18.7%; Adjusted EBITDA decreased 6% to $120.3 million for the last twelve months
  • Quarterly dividend of $0.10 per share is payable May 29, 2024, to shareholders of record as of May 14, 2024
Read the filing on SEC.gov ↗
HCCWARRIOR MET COAL, INC. May 1, 4:05 PM ET

Warrior Met Coal Q1 profit falls to $137.0 million; 2024 guidance reaffirmed

Negative earnings Written later 2.02

Warrior Met Coal reported first quarter 2024 net income of $137.0 million, or $2.62 per diluted share, down from $182.3 million, or $3.51 per diluted share, a year earlier. Total revenues were $503.5 million, compared with $509.7 million, and Adjusted EBITDA fell to $200.2 million from $259.4 million. The company kept its full-year 2024 sales, production and cost guidance unchanged, while noting weaker steelmaking coal prices since early March.

  • Net income $137.0 million ($2.62 per diluted share) vs. $182.3 million ($3.51) in Q1 2023
  • Total revenues $503.5 million vs. $509.7 million; Adjusted EBITDA $200.2 million vs. $259.4 million
  • Sales volume rose 9% to 2.1 million short tons, but average net selling price fell 9% to $233.91 per short ton
  • 2024 guidance re-affirmed, including coal sales of 7.4 to 8.2 million short tons; $0.58 per share returned to stockholders in Q1
Read the filing on SEC.gov ↗
EXTREXTREME NETWORKS INC May 1, 7:11 AM ET

Extreme Networks Q3 revenue down 36.5% to $211.0 million; GAAP loss of $0.50 a share

Negative earnings Written later 2.02

Extreme Networks reported fiscal third-quarter 2024 results for the quarter ended March 31, 2024. Revenue fell 36.5% year over year to $211.0 million, and the company posted a GAAP net loss of $64.4 million, or $0.50 per diluted share, compared with earnings of $0.17 per share a year earlier. For shareholders, the sharp revenue decline and loss weigh on the results, though the company guided to sequential revenue growth of $250.0 million to $260.0 million for the fourth quarter.

  • Revenue was $211.0 million, down from $332.5 million a year earlier; SaaS ARR rose 38.0% to $162.0 million
  • GAAP net loss was $64.4 million ($0.50 per diluted share), versus net income of $22.1 million a year earlier
  • Quarter-end cash was $151.0 million; free cash flow was negative $73.6 million for the quarter
  • Fourth-quarter fiscal 2024 revenue guidance is $250.0 million to $260.0 million; GAAP EPS guidance is ($0.11) to ($0.05)
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.